Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Medical Marijuana Strains in Multiple Sclerosis
NCT03172741Phase 3Withdrawn
- Sponsor
- Colorado State University
- Start
- Jan 2017
- Primary completion
- Jan 2018
- Modality
- Small Molecules
01
Overview
Phase 3, randomised, double-blind trial of cannabis in multiple sclerosis (MS) (4 arms), sponsored by Colorado State University. Primary endpoints: Isometric Strength of the knee extensors, knee flexors, plantar flexors, and dorsi-flexors at 1 year, Fatigue Severity Scale at 1 year and 6 more. Planned start Jan 2017; status: withdrawn.
02
Drugs
cannabis
03
Conditions
multiple sclerosis (MS)
Beyond the preview
Go deeper on NCT03172741.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03172741.